Neurocrine Biosciences (NBIX) Shares Outstanding (Diluted Average) (2016 - 2021)
Historic Shares Outstanding (Diluted Average) for Neurocrine Biosciences (NBIX) over the last 12 years, with Q3 2021 value amounting to $97.9 million.
- Neurocrine Biosciences' Shares Outstanding (Diluted Average) fell 10.2% to $97.9 million in Q3 2021 from the same period last year, while for Sep 2021 it was $97.9 million, marking a year-over-year decrease of 10.2%. This contributed to the annual value of $97.8 million for FY2020, which is 61.73% up from last year.
- According to the latest figures from Q3 2021, Neurocrine Biosciences' Shares Outstanding (Diluted Average) is $97.9 million, which was down 10.2% from $98.0 million recorded in Q2 2021.
- Over the past 5 years, Neurocrine Biosciences' Shares Outstanding (Diluted Average) peaked at $98.2 million during Q2 2020, and registered a low of $87.3 million during Q1 2017.
- In the last 5 years, Neurocrine Biosciences' Shares Outstanding (Diluted Average) had a median value of $96.6 million in 2019 and averaged $94.8 million.
- As far as peak fluctuations go, Neurocrine Biosciences' Shares Outstanding (Diluted Average) skyrocketed by 685.71% in 2017, and later fell by 20.37% in 2021.
- Over the past 5 years, Neurocrine Biosciences' Shares Outstanding (Diluted Average) (Quarter) stood at $92.7 million in 2017, then increased by 2.96% to $95.4 million in 2018, then grew by 1.89% to $97.2 million in 2019, then increased by 0.62% to $97.8 million in 2020, then increased by 0.1% to $97.9 million in 2021.
- Its Shares Outstanding (Diluted Average) stands at $97.9 million for Q3 2021, versus $98.0 million for Q2 2021 and $98.2 million for Q1 2021.